How effective is ustekinumab for plaque psoriasis?

In two major studies involving 1996 adult patients, ustekinumab was more effective than placebo(dummy treatment)in treating moderate to severe plaque psoriasis. More than half of these patients are ineffective, intolerant, or intolerant of other treatments for psoriasis. The primary measure of effectiveness is the number of patients whose symptom scores improve by 75% or more after 12 weeks. Combining results from the two main studies in adults, after 12 weeks, symptoms improved in approximately 69% of patients who received ustekinumab and in approximately 3% of patients who received placebo. Long-term results from these studies indicate that symptomatic improvements with ustekinumab are maintained over 5 years of continuous treatment. One study comparing ustekinumab to etanercept (another drug used for psoriasis) found that ustekinumab was more effective than etanercept after 12 weeks of treatment. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.